How to treat functional hypogonadism

Description

Abraham Morgentaler, MD, FACS, gives an overview of functional hypogonadism, the most common causes of which are obesity and type 2 diabetes. Two patient cases are discussed.

Questions addressed in the presentation include:

Goals of testosterone therapy?

Who is a candidate for treatment?

Is there a therapeutic target level?

Do behavioral interventions help?

Treatment and monitoring

Questions addressed in the presentation include:

Goals of testosterone therapy?

Who is a candidate for treatment?

Is there a therapeutic target level?

Do behavioral interventions help?

Treatment and monitoring


 

Speakers

Professor Abraham Morgentaler

Abraham Morgentaler, MD, FACS
Past President, Androgen Society
Senior Editor, Androgens: Clinical Research And Therapeutics
Associate Professor Of Urology
Harvard Medical School